Gareth is a Client Partner at Prescient, bringing over 15 years of experience in pharmaceutical brand strategy and primary market research. Since joining in August 2014, he has partnered extensively with global and US-based leadership teams, building deep, trusted relationships that enable him to shape strategy at both the asset and portfolio level.
Gareth has significant therapeutic expertise across immunology, neuroscience, and rare diseases, with a strong track record of supporting complex, high-value assets from early development through to launch and lifecycle management. He has led strategic planning for blockbuster biologics in inflammatory bowel disease and dermatology, helping teams define differentiated positioning, sharpen value narratives, and align around clear, actionable brand strategies.
Known for his ability to bring clarity to complexity, Gareth is deeply passionate about brand planning and asset positioning. He ensures that rich customer insight is translated into focused strategic direction—driving alignment across cross-functional stakeholders and enabling consistent, high-quality execution in competitive markets.
Gareth is also a champion of Prescient’s culture and values, and a trusted partner to his clients valued for his strategic thinking, collaborative approach, and commitment to delivering meaningful commercial impact.
